Acadia Pharmaceuticals Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Acadia Pharmaceuticals Inc 's ROA in the second quarter of 2026?
Acadia Pharmaceuticals Inc achieved a return on average assets (ROA) of 24.38 % in its second quarter of 2026, this is above ACAD's average return on assets of -31.63%.
Acadia Pharmaceuticals Inc assets over the 12 months ending in its second quarter of 2026 are valued at $1,561 million

ROA fell compared to the first quarter of 2026, despite the net income growth of 766.1% from the first quarter of 2026.

However, within the Healthcare sector 43 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 153, from total ROA ranking in the first quarter of 2026 at 155.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	42.21 %	41.76 %	24.39 %	43.74 %	42.69 %
Y / Y Net Income Change	18.13 %	-80.84 %	90.32 %	119.07 %	-20.14 %
Net Income (TTM) in million	380	376	391	261	222
Return On Assets (TTM)	24.38 %	26.24 %	29.77 %	21.12 %	19.57 %
ACAD's Total Ranking	# 153	# 155	# 216	# 246	# 210
Total Assets (TTM) in million	1,743	1,605	1,564	1,331	1,226
Seq. Total Assets Change	8.58 %	2.62 %	17.54 %	8.59 %	8.23 %
Seq. Net Income Change	766.1 %	-98.67 %	281.13 %	169.18 %	40.44 %

ACAD's 5 Years Annual ROA >> Back to ACAD Management Effectiveness >> Compare ACAD ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 25
Sector	# 44
Overall	# 166

Return On Assets Statistics
High	Average	Low
29.77 %	-31.63 %	-75.5 %
(Dec 31 2025)		(Sep 30 2018)

Financial Statements
Acadia Pharmaceuticals Inc 's Assets	$ 1,743 million	ACAD's Balance sheet
Acadia Pharmaceuticals Inc 's Income	$ 32 million	Quarterly ACAD's Income Statement
ACAD's Income by Division		See ACAD's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	30.49 %	81.4 %	31.3 %	-17.23 %	-12.73 %
Total Assets in million	1,641	1,257	693	528	638
Y / Y Net Income Change	72.66 %	-	-	-	-
Net Income in million	391	226	-61	-216	-168
Annual Return On Assets	23.83 %	18.01 %	-8.84 %	-40.91 %	-26.32 %

ACAD's 5 Years Annual ROA >> Back to ACAD Management Effectiveness >> Compare ACAD ROA to its Competitors

Comment on ACAD's ROA in the fiscal year ending 2025

In the fiscal year 2025 ROA improved to 23.83 % compared to prior year, due to annual net income growth of 72.66 % to $391.00 million, while value of Acadia Pharmaceuticals Inc 's overall assets grew just by 30.49 % to $1,640.90 million, compared to $1,640.90 a year before.

More Return On Assets Ratios
ACAD's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ACAD's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ACAD's Competitors
Subscribers only: Roa for Acadia Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for ACAD's Customers

You may also want to know
ACAD's Roi	ACAD's Inventory Turnover Ratio	ACAD's Growth Rates	ACAD's Dividend Comparisons
	ACAD's Profitability Ratios	ACAD's Asset Turnover Ratio	ACAD's Dividend Growth
ACAD's Roe	ACAD's Valuation Ratios	ACAD's Financial Strength Ratios	ACAD's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector	ROA
Rallybio Corporation	64.51 %
Oramed Pharmaceuticals Inc	64.18 %
Fortress Biotech Inc	60.88 %
Atlantic Coastal Acquisition Corp Ii	54.09 %
Lensar Inc	47.48 %
Elite Pharmaceuticals Inc	46.11 %
Omeros Corporation	46.05 %
Q32 Bio Inc	45.18 %
Aurinia Pharmaceuticals Inc	44.95 %
Agenus Inc	44.86 %
Earth Science Tech Inc	44.02 %
Liquidia Corporation	36.30 %
Ironwood Pharmaceuticals inc	34.34 %
Idexx Laboratories Inc	33.61 %
Tg Therapeutics Inc	33.59 %
Meiragtx Holdings Plc	29.37 %
Indivior Pharmaceuticals Inc	28.21 %
Qhslab Inc	27.12 %
Adma Biologics Inc	26.58 %
Mettler toledo International Inc	24.86 %
Medpace Holdings Inc	24.84 %
Caredx Inc	24.81 %
Acadia Pharmaceuticals Inc	24.38 %
Eli Lilly And Company	21.97 %
Innoviva Inc	21.64 %
Vaxart Inc	20.85 %
Zevra Therapeutics Inc	20.39 %
Iradimed Corporation	20.36 %
Protalix Biotherapeutics inc	20.09 %
Pro dex Inc	19.87 %

Date modified: 2026-09-11T09:45:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.